SGH
RMD icon

Sivik Global Healthcare’s ResMed RMD Stock Holding History

Sivik Global Healthcare’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,000
Closed -$5.74M – 45
2024
Q2 		$5.74M Sell
30,000
-5,361
-15% -$1.09M 2.06% 20
2024
Q1 		$7M Buy
35,361
+15,361
+77% +$2.81M 1.64% 13
2023
Q4 		$3.44M Buy
+20,000
New +$3.07M 1.44% 34
2017
Q2 		– Sell
-21,200
Closed -$1.53M – 71
2017
Q1 		$1.53M Sell
21,200
-23,800
-53% -$1.64M 0.71% 50
2016
Q4 		$2.79M Buy
+45,000
New +$2.76M 1.33% 31
2014
Q4 		– Sell
-45,000
Closed -$2.22M – 71
2014
Q3 		$2.22M Buy
+45,000
New +$2.29M 1.01% 50

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Sivik Global Healthcare's RMD Position: Q3 2024 in Review

Sivik Global Healthcare sold out of ResMed (RMD) in Q3 2024, closing a stake of 30,000 shares — an estimated $5.74M sold.

Sivik Global Healthcare first reported a position in RMD in Q3 2014 and held it in 6 quarters. The position peaked at $7M in Q1 2024. 801 funds tracked by Wall St. Rank hold RMD as of Q3 2024.

  • Sivik Global Healthcare reported no remaining ResMed position as of Q3 2024 after selling out during the quarter.
  • Sivik Global Healthcare sold 30,000 ResMed shares in Q3 2024, an estimated $5.74M.
  • Sivik Global Healthcare first reported a position in ResMed in Q3 2014 and held it in 6 quarters.
  • Sivik Global Healthcare's ResMed position peaked at $7M in Q1 2024.
  • 801 funds tracked by Wall St. Rank held ResMed as of Q3 2024.

Based on Sivik Global Healthcare's 13F filing for Q3 2024, filed 6 Nov 2024.